The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry
Open accessAbstract
Herpes simplex virus type‐1 and type‐2 are highly prevalent human pathogens causing life‐long infections. The process of infection begins when the virions bind heparan sulfate moieties present on host cell surfaces. This initial attachment then triggers a cascade of molecular interactions involving multiple viral and host cell proteins and receptors, leading to penetration of the viral nucleocapsid and tegument proteins into the cytoplasm. The nucleocapsid is then transported to the nuclear membrane and the viral DNA is released for replication in the nucleus. Recent studies have revealed that herpes simplex virus entry or penetration into cells may be a highly complex process and the mechanism of entry may demonstrate unique cell‐type specificities. Although specificities clearly exist, past and ongoing studies demonstrate that herpes simplex virus may share certain common receptors and pathways that are also used by many other human viruses. This minireview helps to shed light on recent revelations on the herpes simplex virus entry process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herpes simplex virus infections
Whitley, R. J., & Roizman, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04638-9 · Cited by 1,391
A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry
Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., ROSENBERG, R. D., & Spear, P. G. (1999) · Cell · doi:10.1016/s0092-8674(00)80058-6 · Cited by 1,053
Self-citationRegulated Diversity of Heparan Sulfate*
Lindahl, U., Kusche-Gullberg, M., & Kjellén, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.24979 · Cited by 688
Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus
Sodeik, B., Ebersold, M. W., & Helenius, A. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1007 · Cited by 687
Herpes simplex virus: receptors and ligands for cell entry
Spear, P. G. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00389.x · Cited by 582
Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1
Heldwein, E. E. Z., Lou, H., Bender, F. C., Cohen, G. H., Eisenberg, R. J., & Harrison, S. C. (2006) · Science · doi:10.1126/science.1126548 · Cited by 563
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 497
Self-citationActin- and myosin-driven movement of viruses along filopodia precedes their entry into cells
Lehmann, M. J., Sherer, N. M., Marks, C. B., Pypaert, M., & Mothes, W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503059 · Cited by 403
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Carfı́, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Wiley, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00298-2 · Cited by 391
Nimmerjahn, F., Milosevic, S., Behrends, U., Jaffee, E. M., Pardoll, D. M., Bornkamm, G. W., & Mautner, J. (2003) · European Journal of Immunology · doi:10.1002/eji.200323730 · Cited by 359
Research works printed but not linked: 1
- 10.1172/JCI200113799 · DOI
Cited by
Sorted by citations
Items 101–200 of 291
Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs
Steinbach-Rankins, J. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1756-3 · Cited by 35
Kawabata, A., Oyaizu, H., Maeki, T., Tang, H., Yamanishi, K., & Mori, Y. (2011) · Journal of Virology · doi:10.1128/jvi.05622-11 · Cited by 35
Early Events in Herpes Simplex Virus Lifecycle with Implications for an Infection of Lifetime
Salameh, S. (2012) · The Open Virology Journal · doi:10.2174/1874357901206010001 · Cited by 35
Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases
Zhu, L., & Zhu, H. (2014) · Virologica Sinica · doi:10.1007/s12250-014-3539-2 · Cited by 35
Praena, B., Bello‐Morales, R., & López‐Guerrero, J. A. (2020) · Viruses · doi:10.3390/v12070734 · Cited by 34
Significance of Artificial Intelligence in the Study of Virus–Host Cell Interactions
Elste, J., Saini, A., Mejía-Alvarez, R., Mejía, A., Millán‐Pacheco, C., Swanson-Mungerson, M. A., & Tiwari, V. (2024) · Biomolecules · doi:10.3390/biom14080911 · Cited by 38
Wang, A., Chen, F., Wang, Y., Shen, M., Xu, Y., Jian, H., Wang, S., Geng, F., Wang, C., Ran, X., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02209-12 · Cited by 33
Gangji, R. N., Sankaranarayanan, N. V., Elste, J., Al‐Horani, R. A., Afosah, D. K., Joshi, R., Tiwari, V., & Desai, U. R. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00364 · Cited by 33
Bag, P., Ojha, D., Mukherjee, H., Halder, U. C., Mondal, S., Chandra, N. S., Nandi, S., Sharon, A., Chawla‐Sarkar, M., Chakrabarti, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077937 · Cited by 32
RetractedRole of necroptosis in infection‐related, immune‐mediated, and autoimmune skin diseases
Liu, L., Tang, Z., Zeng, Y., Liu, Y., Zhou, L., Yang, S., & Wang, D. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15929 · Cited by 33
Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo
Dai, W., Wu, Y., Bi, J., Wang, S., Li, F., Kong, W., Barbier, J., Cintrat, J., Gao, F., Gillet, D., et al. (2018) · Viruses · doi:10.3390/v10030119 · Cited by 32
Tang, Q., Qin, D., Lv, Z., Zhu, X., Ma, X., Yan, Q., Zeng, Y., Guo, Y., Feng, N., & Lu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031652 · Cited by 32
Viruses of the oral cavity: Prevalence, pathobiology and association with oral diseases
Thakkar, P., Banks, J. M., Rahat, R., Brandini, D. A., & Naqvi, A. R. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2311 · Cited by 36
Zhang, M., Fu, M., Li, M., Hu, H., Gong, S., & Hu, Q. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000418 · Cited by 30
Equid Herpesvirus Type 1 Activates Platelets
Stokol, T., Yeo, W. M., Burnett, D. L., DeAngelis, N., Huang, T., Osterrieder, N., & Catalfamo, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122640 · Cited by 29
Inhibition of Curcumin-Treated Herpes Simplex Virus 1 and 2 in Vero Cells
Flores, D. J., Lee, L. H., & Adams, S. D. (2016) · Advances in Microbiology · doi:10.4236/aim.2016.64027 · Cited by 29
Human TMEFF1 is a restriction factor for herpes simplex virus in the brain
Chan, Y.-H., Liu, Z., Bastard, P., Khobrekar, N. V., Hutchison, K. M., Yamazaki, Y., Fan, Q., Matuozzo, D., Harschnitz, O., Kerrouche, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07745-x · Cited by 29
Viroimmunotherapy for breast cancer: promises, problems and future directions
Chaurasiya, S., & Fong, Y. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-00265-6 · Cited by 28
Dendritic cells in the cornea during Herpes simplex viral infection and inflammation
Kwon, M. S., Carnt, N. A., Truong, N. R., Pattamatta, U., White, A. J. R., Samarawickrama, C., & Cunningham, A. L. (2017) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2017.11.001 · Cited by 28
Antiviral Potential of Sea Urchin Aminated Spinochromes against Herpes Simplex Virus Type 1
Mishchenko, N. P., Nv, K., Iunikhina, O. V., Васильева, Е. А., Николаевна, Л. Г., Pislyagin, Е. А., Владимировна, Т. Д., Dmitrenok, P. S., & Fedoreyev, S. A. (2020) · Marine Drugs · doi:10.3390/md18110550 · Cited by 27
Viral Infection and Antiviral Treatments in Ocular Pathologies
Petrillo, F., Petrillo, A., Sasso, F. P., Schettino, A., Maione, A., & Galdiero, M. (2022) · Microorganisms · doi:10.3390/microorganisms10112224 · Cited by 27
Shukla, N., Tiwari, V., & Vályi-Nagy, T. (2012) · Europe PMC (PubMed Central) · Cited by 27
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis
Koganti, R., Memon, A., & Shukla, D. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1725068 · Cited by 24
Self-citationHost receptors: the key to establishing cells with broad viral tropism for vaccine production
Dai, X., Zhang, X., Ostrikov, K., & Abrahamyan, L. G. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1735992 · Cited by 25
Potential Use of Atlantic Cod Trypsin in Biomedicine
Gudmundsdóttir, Á., Hilmarsson, H., & Stefansson, B. (2013) · BioMed Research International · doi:10.1155/2013/749078 · Cited by 28
Dengue Virus Cellular Receptors and Tropism
Valle, J. R., Salas-Benito, J. S., Soto-Acosta, R., & del Angel, R. M. (2014) · Current Tropical Medicine Reports · doi:10.1007/s40475-013-0002-7 · Cited by 24
Karasneh, G. A., Ali, M. M., & Shukla, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025252 · Cited by 24
Self-citationNordén, R., Halim, A., Nyström, K., Bennett, E., Mandel, U., Olofsson, S., Nilsson, J., & Larson, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616409 · Cited by 24
In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections
Szczubiałka, K., Pyrć, K., & Nowakowska, M. (2015) · RSC Advances · doi:10.1039/c5ra22896d · Cited by 24
Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?
Halford, W. P. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.910121 · Cited by 23
Zhang, Y., Zhang, X., Li, Z., Zhao, W., Yang, H., Zhao, S., Tang, D., Zhang, Q., Li, Z., Liu, H., et al. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.08.031 · Cited by 23
A Preclinical Model for Studying Herpes Simplex Virus Infection
Tajpara, P., Mildner, M., Schmidt, R. L. J., Vierhapper, M. F., Matiasek, J., Popow‐Kraupp, T., Schuster, C., & Elbe‐Bürger, A. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.034 · Cited by 22
Wang, X., Xie, G., Liao, J., Yin, D., Guan, W., Pan, M., Jingnian, L., & Li, Y. (2011) · Virology Journal · doi:10.1186/1743-422x-8-232 · Cited by 21
Sato, Y., Koshizuka, T., Ishibashi, K., Hashimoto, K., Ishioka, K., Ikuta, K., Yokota, S., Fujii, N., & Suzutani, T. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12483 · Cited by 21
Anti-herpes activity of polysaccharide fractions from Stevia rebaudiana leaves
Ceole, L. F., Companhoni, M. V. P., Lopes, S. M. S., de Oliveira, A. J. B., Gonçalves, R. A. C., Filho, B. P. D., Nakamura, C. V., & Ueda‐Nakamura, T. (2018) · Natural Product Research · doi:10.1080/14786419.2018.1516662 · Cited by 20
Puma, D. D. L., Marcocci, M. E., Lazzarino, G., Chiara, G. D., Tavazzi, B., Palamara, A. T., Piacentini, R., & Grassi, C. (2020) · Glia · doi:10.1002/glia.23895 · Cited by 22
Zhang, M., Deng, X., Guan, X., Geng, L., Fu, M., Zhang, B., Chen, R., Hu, H., Hu, K., Zhang, D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02932 · Cited by 19
Luo, M., Shi, X., Guo, J., Lin, K., Zhu, W., Fu, J., Wang, L., & Dong, Z. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739767 · Cited by 19
Human Herpesvirus-6 Entry into Host Cells
Tang, H., & Mori, Y. (2010) · Future Microbiology · doi:10.2217/fmb.10.61 · Cited by 19
Thakkar, N., Jaishankar, D., Agelidis, A. M., Yadavalli, T., Mangano, K., Patel, S., Tekin, S. Z., & Shukla, D. (2017) · Scientific Reports · doi:10.1038/srep42559 · Cited by 19
Self-citationThe role of herpesviruses in ocular infections
Shukla, D., Farooq, & Shah (2010) · Virus Adaptation and Treatment · doi:10.2147/vaat.s9500 · Cited by 19
Self-citationKretschmer, M., Diez, R. C., Butnarasu, C., Silveira, V., Dobryden, I., Visentin, S., Berglund, P., Sönnerborg, A. B., Lieleg, O., Crouzier, T., et al. (2022) · Advanced Science · doi:10.1002/advs.202203898 · Cited by 17
The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus
Cohen, T. S. D., Schwarz, T. M., Vigant, F., Gardner, T. J., Hernandez, R. E., Lee, B., & Tortorella, D. (2016) · Viruses · doi:10.3390/v8100295 · Cited by 18
Inhibition of Herpes Simplex Viruses, Types 1 and 2, by Ginsenoside 20(S)-Rg3
Wright, S., & Altman, E. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1908.08047 · Cited by 17
Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells
Crisci, E., Ellegård, R., Nyström, S. N., Rondahl, E., Serrander, L., Bergström, T. B., Sjöwall, C., Eriksson, K., & Larsson, M. (2016) · Journal of Virology · doi:10.1128/jvi.00224-16 · Cited by 17
Ocular diseases: immunological and molecular mechanisms
Song, J., Huang, Y., Zhang, W., Chen, X., & Guo, Y.-M. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.05.25 · Cited by 17
Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro
Dai, W. W., Wu, Y., Bi, J. P., Wang, J. Y., Wang, S., Kong, W., Barbier, J., Cintrat, J., Gao, F., Jiang, Z. R., et al. (2018) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1712.12052 · Cited by 16
Modulation of Endosome Function, Vesicle Trafficking and Autophagy by Human Herpesviruses
Tognarelli, E. I., Reyes, A., Corrales, N., Carreño, L. J., Bueno, S. M., Kalergis, A. M., & González, P. A. (2021) · Cells · doi:10.3390/cells10030542 · Cited by 17
Anti-herpes simplex virus activities and mechanisms of marine derived compounds
Hao, C., Xu, Z., Xu, C., & Yao, R. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1302096 · Cited by 16
Feng, Y., van Bodegraven, D., Kádek, A., Munguira, I. L. B., Soria-Martínez, L., Nentwich, S., Saha, S., Chardon, F., Kavan, D., Uetrecht, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54373-0 · Cited by 16
Yakoub, A. M., & Shukla, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124646 · Cited by 16
Self-citationAwady, M. E. E., Nasr-Eldin, M. A., Ibrahim, H. M., Bahnasy, M. A., & Aziz, S. W. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.91102 · Cited by 16
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
Guan, M., Romano, G., Coroniti, R., & Henderson, E. E. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-014-0091-8 · Cited by 16
Antoine, T. E., & Shukla, D. (2013) · Antiviral Therapy · doi:10.3851/imp2661 · Cited by 18
Self-citationYe, X., Gui, X., Freed, D. C., Ku, Z., Li, L., Chen, Y., Xiong, W., Fan, X., Su, H., He, X. C., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007914 · Cited by 16
Srisai, P., Suriyaprom, S., Panya, A., Pekkoh, J., & Tragoolpua, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-60941-7 · Cited by 15
Guo, H., Pang, K., Wei, Y., Yi, C., & Wu, X. (2015) · Ophthalmic Research · doi:10.1159/000437209 · Cited by 15
Gonzalez, M. S., Silva, L. F., Albuquerque-Cunha, J. M., Nogueira, N. F. S., de Mattos, D. P., de Castro, D. P., Azambuja, P., & Garcia, E. S. (2011) · Parasitology · doi:10.1017/s0031182011001521 · Cited by 15
Doszpoly, A., Мусаевич, К. И., Breyta, R. B., & Щелкунов, И. С. (2017) · Journal of Fish Diseases · doi:10.1111/jfd.12611 · Cited by 15
Lukić, I., Pajnik, J., Nišavić, J., Tadić, V., Vági, E., Székely, E., & Žižović, I. (2022) · Processes · doi:10.3390/pr10040680 · Cited by 14
Evasión de la respuesta inmune por virus herpes simplex
Retamal-Díaz, A. R., Suazo, P. A., Garrido, I., Kalergis, A. M., & González, P. A. (2015) · Revista chilena de infectología · doi:10.4067/s0716-10182015000200009 · Cited by 14
Forces and Structures of the Herpes Simplex Virus (HSV) Entry Mechanism
Clarke, R. W. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00059 · Cited by 14
Burnham, L., Jaishankar, D., Thompson, J. M., Jones, K. S., Shukla, D., & Tiwari, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00973 · Cited by 14
Self-citationBagley, K., Schwartz, J. A. J., Andersen, H., Eldridge, J. H., Xu, R., Ota‐Setlik, A., Geltz, J. J., Halford, W. P., & FOUTS, T. R. (2017) · Viral Immunology · doi:10.1089/vim.2016.0136 · Cited by 14
Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfate
Diez, R. C., Sepúlveda‐Crespo, D., Maly, M., & Muñoz‐Fernández, M. Á. (2016) · RSC Advances · doi:10.1039/c6ra06969j · Cited by 14
Bacterial and Viral InfectionsPreprint
Szymanski, C. M., Schnaar, R. L., & Aebi, M. (2015) · doi:10.1101/glycobiology.3e.042 · Cited by 15
Induction of Filopodia During Cytomegalovirus Entry Into Human Iris Stromal Cells
Chang, K., Majmudar, H., Tandon, R., Volin, M. V., & Tiwari, V. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.834927 · Cited by 12
Systemic virotherapy for multiple myeloma
Oliva, S., Gambella, M., Boccadoro, M., & Bringhen, S. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1364359 · Cited by 13
Hu, Q., Fink, E. A., Happer, M., & Elder, J. H. (2011) · Journal of Virology · doi:10.1128/jvi.00573-11 · Cited by 14
Aptamers in Virology—A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy
Yadavalli, T., Volety, I., & Shukla, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101646 · Cited by 13
Self-citationThe Host–Pathogen Interplay: A Tale of Two Stories within the Cornea and Posterior Segment
Dempsey, M. P., & Conrady, C. D. (2023) · Microorganisms · doi:10.3390/microorganisms11082074 · Cited by 12
Shen, C. F., Burney, E., Gilbert, R., Elahi, S. M., Parato, K. A., & Loignon, M. (2023) · Biotechnology Journal · doi:10.1002/biot.202300244 · Cited by 12
Bandyopadhyay, C., Veettil, M. V., Dutta, S., & Chandran, B. (2014) · Journal of Virology · doi:10.1128/jvi.01674-14 · Cited by 12
Hu, K., He, S., Xiao, J., Li, M., Luo, S., Zhang, M., & Hu, Q. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000895 · Cited by 12
Stamos, J. D., Lee, L. H., Taylor, C., Elias, T. N., & Adams, S. D. (2022) · Microorganisms · doi:10.3390/microorganisms10071462 · Cited by 12
Deng, L.-M., Zhou, P., Yi, Y., Li, Y., Zheng, H., Wu, X., Cai, C., Zhou, L., Luo, Z., Wu, K., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143943 · Cited by 11
SUMOylation and Viral Infections of the Brain
Imbert, F., Leavitt, G., & Langford, D. (2022) · Pathogens · doi:10.3390/pathogens11070818 · Cited by 12
Al-Kuraishy, H. M., Al-Gareeb, A. I., Hetta, . F., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2023) · AMB Express · doi:10.1186/s13568-023-01517-y · Cited by 10
Ma, N., Shen, M.-X., Chen, T., Liu, Y., Mao, Y., Chen, L., Xiong, H., Hou, W., Liu, D., & Zhan-qiu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109359 · Cited by 10
Abreu, P. A., Giongo, V. A., Boechat, F. D. C. S., Castro, H. C., Riscado, C. S., de Souza, M. T., Ribeiro, C. P., Barbosa, J. E., Santos, C. C. C., Rodrigues, C. R., et al. (2011) · Current Microbiology · doi:10.1007/s00284-010-9860-6 · Cited by 10
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
Ghose, J., Donà, A., Murtadha, M., Gunes, E. G., Caserta, E., Yoo, J. Y., Russell, L., Jaime‐Ramirez, A. C., Barwick, B. G., Gupta, V. A., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.02.009 · Cited by 10
Hoxha, R., Todorov, D. G., Hinkov, A. V., Shishkova, K., Evstatieva, Y., & Nikolova, D. (2023) · Microbiology Research · doi:10.3390/microbiolres14010026 · Cited by 9
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
Raimondi, V., Vescovini, R., Dessena, M., Donofrío, G., Storti, P., & Giuliani, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1483806 · Cited by 12
Tryland, M., das Neves, C. G., Klein, J., Mørk, T., Hautaniemi, M. K., & Wensman, J. J. (2018) · CRC Press eBooks · doi:10.1201/9780429489617-8 · Cited by 9
Viruses Utilize Cellular Cues in Distinct Combination to Undergo Systematic Priming and Uncoating
Ravindran, M. S., & Tsai, B. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005467 · Cited by 9
Delos, M., Hellec, C., Foulquier, F., Carpentier, M., Allain, F., & Denys, A. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12145 · Cited by 8
Gao, Y., Cheng, J., Xu, X., Li, X., Zhang, J., Ma, D., Jiang, G., Liao, Y., Fan, S., Niu, Z., et al. (2022) · Viruses · doi:10.3390/v14051046 · Cited by 8
Ichimiya, T., Okamatsu, M., Kinoshita, T., Kobayashi, D., Ichii, O., Yamamoto, N., Sakoda, Y., Kida, H., Kawashima, H., Yamamoto, K., et al. (2021) · Virology · doi:10.1016/j.virol.2021.06.008 · Cited by 8
Emerging drugs for the treatment of herpetic keratitis
Kapoor, D., Sharma, P., & Shukla, D. (2024) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2024.2339899 · Cited by 8
Self-citationKamel, M., Pavulraj, S., Fauler, B., Mielke, T., & Azab, W. (2020) · iScience · doi:10.1016/j.isci.2020.101615 · Cited by 7
Zhang, P., Yan, H., Liang, Z., Zhang, P., Li, X., Yuan, X.-Z., Yu, G., Wang, W., & Cai, C. (2025) · ACS Nano · doi:10.1021/acsnano.4c15060 · Cited by 7
Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells
Bello‐Morales, R., Crespillo, A. J., Praena, B., Tabarés, E., Revilla, Y., García, E., Fraile‐Ramos, A., Baron, W., Krummenacher, C., & López‐Guerrero, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147885 · Cited by 7
Hu, Q., Fink, E. A., Grant, C. K., & Elder, J. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115252 · Cited by 7
Skin Diseases Caused by Factors from the Environment
Ma, L., Chen, M., Fa, Z., Pan, W., Liao, W., Gao, X., Huo, W., Yang, Y., Chen, H., Holahan, H. M., et al. (2016) · Springer eBooks · doi:10.1007/978-94-024-0902-4_8 · Cited by 7
Afzal, M. Z., & Shirai, K. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000265 · Cited by 7
Yersinia pseudotuberculosis cytotoxic necrotizing factor interacts with glycosaminoglycans
Kowarschik, S., Schöllkopf, J., Müller, T. S., Tian, S., Knerr, J., Bakker, H., Rein, S., Dong, M., Weber, S., Grosse, R., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001630r · Cited by 7
Glycoproteins of HHV-6A and HHV-6B
Tang, H., & Mori, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-7230-7_8 · Cited by 6
Kadam, R., Patil, C. D., Feferman, L., Maienschein‐Cline, M., Chlipala, G. E., Borole, P., Bhattacharya, I., Orameh, C., Nyugen, T., Tseng, H., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117263 · Cited by 6
Self-citationOh, P., Han, Y., Lim, S. T., & Jeong, H. (2022) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2022.112632 · Cited by 6
Monkeypox epidemic at the door: should we remain idly by or prepare strongly?
Al-Kuraishy, H. M., Al-Gareeb, A. I., Hetta, . F., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2023) · AMB Express · doi:10.1186/s13568-023-01507-0 · Cited by 6
Metadata
- Authors
- Akhtar, J., & Shukla, D.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Shukla, Deepak
- ORCID
- Shukla, Deepak
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2009-11-27
- Volume
- 276
- Issue
- 24
- Pages
- 7228-7236
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- PMC
- PMC2801626
- OpenAlex
- W1501808502
- Cited by
- 292
- References
- 48
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 17 · 2023: 15 · 2022: 17 · 2021: 18 · 2020: 19 · 2019: 14 · 2018: 18 · 2017: 23 · 2016: 23 · 2015: 21 · 2014: 20 · 2013: 17 · 2012: 20
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- FEBS Journal (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Research to Prevent Blindness
- National Institutes of Health
- National Eye Institute (EY 01792, P30EY001792)
- National Institute of Allergy and Infectious Diseases (R01AI057860)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- herpes simplex virus type 1, herpes simplex virus type 2, viral entry, heparan sulfate, viral attachment, tegument proteins, viral DNA replication, cell type specificity, host-virus interaction
- MeSH terms
- Cell Communication, Humans, Membrane Fusion, Membrane Glycoproteins, Pseudopodia, Receptors, Immunologic, Viral Envelope Proteins, Herpesvirus 2, Human, Herpesvirus 1, Human, Heparan Sulfate Proteoglycans, Virus Internalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review